Remove Life Sciences Remove Prevention Remove Regulations Remove Telemedicine
article thumbnail

Risky Business of Health Trackers: What Digital Health Leaders Need to Know

HIT Consultant

Cristina Varner, Newfront, SVP National Life Science & Healthcare Practice Gone are the days when healthcare information was only available to us at the doctor’s office or through the office’s online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices.

article thumbnail

5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials

HIT Consultant

Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. These insights help regulators, payers and providers understand treatments through the eyes of the patient, including how symptoms and adverse events impact study medication adherence and quality of life across patient populations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roundup: Genomics biobank built in Africa, UK social care bodies to appoint Caldicott Guardians by 2023 and more briefs

Healthcare It News

We understand the importance and significant opportunity involved in ensuring that African data is represented in Life Sciences research in the near to long term. The added pressure of the COVID-19 pandemic on providers has made any solution that saves time and promotes telemedicine essential.

article thumbnail

Monopolization in Healthcare Could Affect Access to Quality Treatment

HIT Consultant

Healthcare needs to take a lesson from other industries already in the throes of monopolies to prevent a decrease in competition and ultimately, a disaster for patients. It is important to exercise caution with the concentration of the telemedicine as it could lead to additional care issues.

article thumbnail

What HealthyThinker Is Thinking About Health at CES 2020

Health Populi

I’ve also scheduled get-togethers with pharma and life science folks, health plan people, and execs from consumer health companies. Healthcare is getting serious at #CES2020, blurring into the medical and FDA regulated turf which Omron pioneered last year launching its 80+-patented blood pressure watch, the HeartGuide.

article thumbnail

Our Homes Are Health Delivery Platforms – The New Home Health/Care at CES 2021

Health Populi

billion , approved by the European Union antitrust regulators with some pretty strong teeth about how Fitbit data should not be used in Google ad flow. As we’ve been so focused on digital health tech, it’s timely to note that Google recently completed its purchase of Fitbit for $2.1 The deal has not yet been approved by the U.S.